Lp(a)
The latest news about Lp(a): headlines, AI summaries and the full story from every source.
- Novartis' Failed Cholesterol Drug Trial Raises Questions About Amgen and Eli Lilly's Experimental Treatments
- Amgen Stock Drops Sharply Amid Novartis' Lp(a)-Lowering Drug Failure
- Novartis' Pelacarsen Clinical Failure Impacts Cardiovascular Drug Race and Eli Lilly
- Amgen Shares Drop After Novartis' Lp(a)-Lowering Drug Fails in Trial
- Novartis' Cholesterol Drug Fails in Cardiovascular Trial, Casting Doubt on Lp(a) Treatment Race
- Ionis Pharmaceuticals Shares Drop After Pelacarsen Fails Key Phase 3 Heart Trial